enVVeno Medical
NVNO
24 hedge funds and large institutions have $13.7M invested in enVVeno Medical in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
3,918% more call options, than puts
Call options by funds: $2.61M | Put options by funds: $65K
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
60% more funds holding
Funds holding: 15 → 24 (+9)
57% more capital invested
Capital invested by funds: $8.74M → $13.7M (+$4.97M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0.37% more ownership
Funds ownership: 0.25% → 0.63% (+0.37%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$6.29M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$1.76M |
| 3 |
Two Sigma Advisers
New York
|
+$651K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$644K |
| 5 |
Two Sigma Investments
New York
|
+$542K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$924K |
| 2 |
LSA
L & S Advisors
Los Angeles,
California
|
-$311K |
| 3 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$164K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$127K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$39.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Marshall Wace
London,
United Kingdom
| – | -$127K | -349 | Closed |
|
NVNO Hedge Fund Activity: Q4 2021 in Review
24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q4 2021, worth a combined $13.7M — up 57% from $8.74M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NVNO positions and 3 closed out — a net gain of 9 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $6.29M. The largest seller was Morgan Stanley, cutting an estimated $924K.
- 24 institutional investors held enVVeno Medical (NVNO) as of Q4 2021, up from 15 in Q3 2021.
- Funds reported $13.7M of enVVeno Medical stock for Q4 2021, up 57% quarter-over-quarter.
- 12 funds opened new enVVeno Medical positions in Q4 2021 and 3 closed out, a net change of +9 holders.
- The largest enVVeno Medical buyer in Q4 2021 was Perceptive Advisors, an estimated $6.29M added.
- The largest enVVeno Medical seller in Q4 2021 was Morgan Stanley, an estimated $924K sold.
Based on aggregated 13F filings for Q4 2021.